Quick Search 
Methods and Findings
Register or sign in

  
 
  
Volume 25, Suppl. A, October 2003, Pages 3-

XXV Congress of the Spanish Society of Pharmacology
October 8-11, 2003
Cádiz, Spain

CONFERENCES

Role of 5-HT1A and 5-HT2A Serotonergic Receptors in the Treatment of Depression and Schizophrenia F. Artigas
Full Article (6 Kb)

Regulation and Signaling of Opioid Receptors in the Brains of Opiate Addicts J.A. García Sevilla
Full Article (9 Kb)

ROUND TABLES

I - Innovations in Teaching Practices in Pharmacology
Teaching Aspects of Practical Courses in Pharmacology in the New "European Higher Education Area" J.E. Baños
Full Article (9 Kb)

The Practice-Teaching Situation of Pharmacology in Spain M.V. Clos
Full Article (8 Kb)

The Controversy over Animal Use in the Practical Courses of Pharmacology in Health Science Schools I. Bellido, J.E. Baños, M.V. Clos, M.D. Ivorra, J.J. Meana and S. Sánchez
Full Article (15 Kb)

Learning to Research in a Pharmacology Course: The Experience of the University of the Basque Country J.J. Meana
Full Article (13 Kb)

II - Neuropsychopharmacology: Schizophrenia, Psychosis and Affective Disorders
Glutamate and Schizophrenia C. Matute
Full Article (4 Kb)

Noradrenergic System Implications in Depressive Disorders J.J. Meana
Full Article (11 Kb)

III - Neuropsychopharmacology: Schizophrenia, Psychosis and Affective Disorders. From the Laboratory to the Clinic
Antipsychotics C. Arango López
Full Article (4 Kb)

Antidepressives. "Where We Are and Where We Are Going" V. Pérez Sola
(Text not received)

IV - Neuropsychopharmacology: Pain
New Mechanisms Involved in the Antinociception and Tolerance Induced by Agonists of
m-Opioid Receptors J.M. Baeyens
Full Article (9 Kb)

Antidepressants and Pain J.A. Micó
Full Article (8 Kb)

V - Neuropharmacology: Neurodegenerative Disorders
Advances in the Pharmacology and Treatment of Parkinson's Disease P. Jenner
Full Article (5 Kb)

Neurochemistry in Alzheimer's Disease R. Rodríguez
(Text not recieved)

VI - Strategy and Methodology in the Discovery of New Drugs. From Candidates to Clinical Studies
Strategy and Tactics in Target Validation J. Beleta
Full Article (5 Kb)

High Throughput Screening as a Tool for the Lead Finding Process T. Doménech
Full Article (6 Kb)

Molecular Design in the Pharmaceutical Industry: Possibilities, Results and the Future J. Quintana
Full Article (3 Kb)

Lead Optimization: Process to Design Preclinical Candidates L.A. Gómez-Casajús
Full Article (4 Kb)

Developmental Pharmacology. Behavioral Assays in Antipsychotics A. Brasó, M. Princep, M. Schmid, A. Tabernero, C. Perez and A. Guglietta
Full Article (7 Kb)

Safety Pharmacology, Pharmacokinetics and Toxicology. An Obstacle Race in the Development of a Pharmaceutical Compound A. Gúzman
Full Article (6 Kb)

VI - Clinical Investigation of New Pharmacological Targets: From Speculation to Clinical Confirmation
Researching New Pharmacological Targets: From Speculation to Clinical Confirmation I. Izquierdo
Full Article (4 Kb)

Exploratory and Confirmatory Studies in Humans: Relevant Criteria in Pharmacokinetics J. Ramis
Full Article (6 Kb)

Phase I-IIa in Neuropharmacology. Is the Proof of Concept Feasible? M.J. Barbanoj, R.M. Antonijoan, C. García-Gea, M. Valle and F. Jané
Full Article (8 Kb)

Phase III Clinical Trials in Psychiatry A. González-Pinto
Full Article (5 Kb)

Clinical Trials in Psychiatry: The Placebo Effect I. Gilaberte
Full Article (4 Kb)

Regulatory Issues in Psychopharmacology. European Union Perspective G. Calvo
Full Article (5 Kb)

VII - Therapeutic Innovations
Esomeprazole: A Step Ahead in Acid Control J. Zapardiel
(Text not received)

Glatiramer Acetate and Multiple Sclerosis J.A. García Merino
Full Article (4 Kb)

Spiriva: A New Treatment for EPOC. Clinical Results G. de Miquel
(Text not received)

Bexarotene, a New Option for the Treatment of CTCL, Approved by the FDA and the EMEA I. Zsolt
Full Article (6 Kb)

Racecadotril R. Lozano Fernández de Pinedo
Full Article (5 Kb)

Memantine: A New Alternative for Alzheimer's Disease L. Gandía
(Text not received)

The Discovery and Properties of Caspofungin(R), an Antifungal Agent that Inhibits Fungal Glucan Synthesis F. Peláez
Full Article (4 Kb)

Imatinib in Chronic Myeloid Leukemia F. Fernández
(Text not received)

Ziprasidone: A Promising Alternative in the Treatment of Schizophrenia M. Madrigal, T. Díez, M. Cano
Full Article (5 Kb)

Thromoboprophylaxis in Patients Undergoing Major Orthopedic Surgery. Is There a Need for New Drugs? M. Monreal
Full Article (5 Kb)

Innovative Aspects of Alemtuzumab (Mabcampath) M. Alcocer
(Text not received)

ORAL COMMUNICATIONS

Teaching Round Table
Full Article (4 Kb)

Session I
Full Article (3 Kb)

Session II
Full Article (3 Kb)

Session III
Full Article (3 Kb)

Session IV
Full Article (3 Kb)

POSTERS

Session I
Full Article (17 Kb)

Session II
Full Article (17 Kb)

PHARMACOLOGY AWARD 2002
Chemokines Involved in Angiotensin-II-Induced Leukocyte-Endothelial Cell Interaction and Modulation by both Natural and Semisynthetic Products M.A. Blázquez, L. Milián, T. Mateo, P.J. Jose and M.J. Sanz
Full Article (7 Kb)

LIST OF AUTHORS
Full Article (48 Kb)

GENERAL INDEX
Full Article (17 Kb)


 
  



© 2020 Clarivate Analytics. All rights reserved.
Copyright NoticeTerms of UsePrivacy StatementCookie Policy